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INTRODUCTION 
Systemic lupus erythematosus (SLE) is 
an autoimmune disease of unknown etiology 
that can affect various organs and systems. 
Since it predominantly affects women (in 
the proportions of 9 to 1) and since in the 
majority of cases it is diagnosed between 
the ages of 20 and 40, it is the connective tissue 
disease that is most frequently associated with 
pregnancy and the puerperium. Remission 
of the disease around the time of conception 
is related to favorable pregnancy outcome.1,2 
On the other hand, a diagnosis of SLE during 
pregnancy and fl are-up around the time of 
conception or during pregnancy are related 
to poor prognosis for both the pregnancy and 
the course of the disease.1
Abortion, intrauterine growth restric-
tion, prematurity, and perinatal morbidity 
and mortality are among the most common 
adverse perinatal outcomes in pregnant lupus 
patients. Flare-ups, nephritis and arterial 
hypertension are factors that increase the risk of 
perinatal complications,2,3 as is an association 
with antiphospholipid antibody syndrome 
(APS), which is present in 30-40% of SLE 
cases.4 Although rare, neonatal lupus is also a 
complication that may be serious and should 
always be considered in this population.  
The adverse perinatal outcomes resul-
ting from SLE are believed to occur as a 
consequence of immunological alterations in 
the placenta. The histology of the placenta 
frequently reveals vascular abnormalities in 
the uteroplacenta or alterations in coagula-
tion. These lesions are generally similar to 
those found in preeclampsia, hypertension 
and diabetes mellitus.1,5,6 Improvements in 
the treatment and control of systemic lupus 
erythematosus have led to better quality of life 
for patients with this pathological condition 
and a consequent increase in the number of 
pregnancies in this population.7
OBJECTIVE 
The objective of the present study was to 
evaluate the clinical evolution, perinatal out-
comes and most frequently observed placental 
alterations among pregnant lupus patients, 
according to the presence or absence of disease 
fl are-ups. These women were receiving care 
at a specialized prenatal clinic, Centro de 
Atenção Integral à Saúde da Mulher (Women’s 
Full Healthcare Clinic), Universidade Estadual 
de Campinas (CAISM/Unicamp), over an 
eight-year period, and they gave birth at the 
same institution.
METHODS
This observational cohort study was 
carried out at the specialized prenatal clinic 
CAISM/Unicamp, which is a tertiary clinic for 
high-risk pregnancies. The patients included 
in the study were followed up according to 
a specifi c protocol for the care of pregnant 
women with lupus, including investigation of 
the current clinical and laboratory conditions 
(cardiac, immunological, renal, hematological 
and hepatic status). They delivered their babies 
at the same institution between 1995 and 
2002. A total of 67 women and 76 pregnancies 
were included in the study. They represent all 
of the cases with SLE that were managed at 
this service during this period. There was no 
loss to follow-up.
Data were collected on a precoded form 
and data entry was performed using the Epi-
Info software program, version 6.1. After 
evaluating the general characteristics of the 
sample, the women were divided into two 
groups according to the presence or absence 
of fl are-ups of the disease during pregnancy, 
as defi ned by the systemic lupus erythemato-
sus disease activity index (SLEDAI).8 They 
were also divided into two groups according 
to whether renal involvement with SLE was 
detected or not. 
CONTEXT AND OBJECTIVE: Systemic lupus 
erythematosus is a chronic disease that is more 
frequent in women of reproductive age. The 
relationship between lupus and pregnancy is 
problematic: maternal and fetal outcomes are 
worse than in the general population, and 
the management of fl are-ups is diffi cult during 
this period. The aim here was to compare the 
outcomes of 76 pregnancies in 67 women with 
lupus, according to the occurrence or absence 
of fl are-ups.  
DESIGN AND SETTING: An observational cohort 
clinical study evaluating the evolution of pregnant 
women with lupus who were receiving care at the 
prenatal outpatient clinic, Centro de Atenção In-
tegral à Saúde da Mulher, Universidade Estadual 
de Campinas (CAISM/Unicamp), between 1995 
and 2002.
METHODS: Data were collected on a precoded 
form. The women were divided into two groups ac-
cording to the occurrence or absence of fl are-ups, 
as defi ned by the systemic lupus erythematosus 
disease activity index (SLEDAI). The presence or 
absence of fl are-ups and renal involvement was 
considered to be the independent variable and the 
other results were dependent variables.
RESULTS: Flare-ups occurred in 85.3% of cases, 
and were most signifi cant when there was renal 
involvement. This was related to greater numbers 
of women with preeclampsia and poor perinatal 
outcome. Intrauterine growth restriction was 
more common in the women with active disease. 
Placental weight was signifi cantly lower in the 
women with renal involvement. 
CONCLUSIONS: Flare-ups and renal involve-
ment in lupus patients during pregnancy are 
associated with increased maternal and perinatal 
complications.
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Statistical analysis was carried out after 
performing consistency tests. Qualitative 
variables were analyzed using the χ² test 
and, when applicable, Fisher’s exact test. 
Student’s t test was used for comparison 
of the means of continuous quantitative 
variables. Statistical significance was esta-
blished as p < 0.05. The study obtained 
prior approval from the institution’s Re-
search Ethics Committee.
RESULTS
During the study period, there were 
23,676 deliveries at the institution, of which 
76 occurred among lupus patients. There-
fore, the rate of deliveries to lupus patients 
at this institution was 3.21:1000. The mean 
age of the lupus patients was 25.9 years 
(range: 18-39 years), and these patients had 
had between one and seven pregnancies, in-
cluding the current one.  Around 22.4% of 
the women had previously miscarried. The 
women in this study had attended a mean of 
8.5 prenatal consultations. The mean time 
elapsed between diagnosis of lupus and com-
mencement of pregnancy was 48.9 months, 
i.e. four to fi ve years (Table 1).
Of the 76 cases studied, 47 (61.8%) fulfi lled 
the diagnostic criteria established by the Ameri-
can College of Rheumatology (ACR), while 
17 (22.4%) had probable lupus (three positive 
criteria) and 12 (15.8%) had possible lupus 
(two positive criteria). The ACR criteria most 
frequently found in this population were: im-
munological disorders, blood abnormalities and 
renal involvement, serositis, butterfl y-shaped 
rash and a positive antinuclear antibody (ANA) 
test (Table 2).
Although the SLEDAI criteria do not 
recommend any specifi c test for evalua-
ting the immunological profi le, the ANA 
test was positive in 73% of cases during 
prenatal follow-up. There were positive 
fi ndings of anti-DNA antibodies in 19%, 
anti-Ro in 37% and anti-La in 11% of the 
cases. Anticardiolipin antibodies (via im-
munoglobulin G and immunoglobulin M 
determination) and/or lupus anticoagulant 
(via Russell viper venom time and kaolin 
clotting time) were detected in 36% of 
the patients. Immunosuppressor treatment 
for SLE was required in 93.4% of the 
pregnant women. The immunosuppressors 
used included prednisone (at doses of 5 to 
80 mg/day) and azathioprine. Antihyperten-
sive drugs were used by 26.7% and aspirin 
and/or heparin by 14% of the women (data 
not presented in table). 
Of the 67 women enrolled in this study, 
20 (26.3%) suffered some form of hyper-
tensive syndrome during pregnancy. Nine 
women (11.8%) had preeclampsia (defi ned 
as the raising of blood pressure after the 
twentieth week of pregnancy plus proteinuria 
above 300 mg over a 24-hour period), and all 
of these patients had some degree of renal in-
volvement. Another three patients (4%) had 
gestational hypertension and eight (10.5%) 
had chronic hypertension. Some degree of 
lupus nephropathy was present in 32 women 
(45.1%) and there was no statistically signifi -
cant difference in gestational loss between 
these patients and the women who had no 
renal alterations. However, the incidence of 
preeclampsia was greater, and the newborn 
infant’s weight and placental weight were 
lower in this group of women.
One maternal death occurred during 
the puerperium. This was a patient who had 
secondary pulmonary hypertension associated 
with lupus and who had had a fl are-up during 
a twin pregnancy. She went into premature 
labor and underwent cesarean section at 
28 weeks due to breech presentation of the 
fi rst twin and premature labor. She developed 
central nervous system vasculitis and died 
from reentrant convulsions on the third day 
of the puerperium.
With regard to the type of delivery, 68.6% 
of the patients underwent cesarean section. 
The principal indication for this was fetal 
distress (32 cases). Of the 76 cases studied, 
14 led to gestational loss. Of these, six were 
miscarriages (7.8%), three were cases of fetal 
death (3.9%) and fi ve were neonatal deaths 
(6.5%) (Table 3). In all the cases in which 
the woman was not a primigravida, she had 
a history of at least one previous miscarriage. 
Among the cases of fetal death, all the patients 
had some degree of renal involvement.
There was one twin pregnancy; the rate 
of prematurity, as defi ned by the Capurro 
method, was 50.0% of all live births. The 
percentages of infants with Apgar score < 
7 at the fi rst and fi fth minutes were 13.4% 
and 3.0%, respectively. The mean weight 
of the newborns was 2,324.35 grams. The 
majority were considered to be adequate for 
gestational age (AGA), while around 22.3% 
were considered small for gestational age 
(Table 3). Among the adverse neonatal out-
comes occurring in the surviving infants, the 
most frequent were intraventricular hemor-
rhage (four cases), patent ductus arteriosus 
(fi ve cases) and congenital dislocation of the 
hip (three cases). There were also two cases 
of thrombocytopenia, in which a diagnosis 
Table 1. General characteristics and history of pregnant lupus patients. Campinas, 
1995-2002
Maternal variables Mean (n = 76) SD
Age (years) 25.9 5.64
Number of prenatal visits 8.5 4.02
Disease duration (months) 48.9 39.0
n %
With history of abortion 17 22.4
First pregnancy 21 27.6
Nulliparous 28 36.8
Without living children 31 40.8
With history of cesarean sections 30 39.5
SD = standard deviation.
Table 2. Frequency of diagnostic criteria (American College of Rheumatology) among 
76 pregnant lupus patients. Campinas, 1995-2002
Criterion n %
Immunological disorder 56 73.7
Hematological disorder 49 64.5
Renal disorder 47 61.8
Antinuclear antibody 46 60.5
Serositis 38 50.0
Butterfl y wing rash 33 43.4
Discoid lupus 23 30.3
Photosensitivity 15 19.7
Arthritis 14 18.4
Mouth ulcer 6 7.9
Neurological disorder 5 5.7
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of neonatal lupus was made. There were no 
cases of atrioventricular blockage.  
Histological examinations were carried 
out on 45 placentas and 44.4% of these were 
found to have no abnormalities. The mean 
placental weight was 403.36 ± 193.3 grams. 
The most common findings were infarct, 
edema and intervillous thrombosis.  
The occurrence of disease fl are-ups during 
pregnancy was defi ned as the presence of any 
of the SLEDAI criteria: hematological, im-
munological, renal, cutaneous, constitutional 
or osteoarticular alterations, or serositis. These 
alterations were analyzed in 68 of the 76 women 
in the study; 58 of them (85.3%) had some 
form of alteration (Figure 1). When the whole 
sample was dichotomized into those who did 
and those who did not have fl are-ups according 
to the SLEDAI criteria, it was observed that 
preeclampsia only developed in those with 
some degree of active disease. The gestational 
loss rate, calculated by adding the percentages of 
miscarriages, fetal deaths and neonatal deaths, 
was not signifi cantly different between the 
two groups. The women with disease fl are-ups 
had a greater number of low-weight infants, 
although there was no difference in relation to 
prematurity or adequate weight for gestational 
age. There were no signifi cant differences in the 
placental analysis, although a greater number 
of placentas with abnormalities were found in 
patients who had fl are-ups (Table 4).  
On the other hand, when the group was 
dichotomized into patients who had and pa-
tients who did not have lupus nephropathy, 
statistically signifi cant differences were seen 
in perinatal outcome. There was a greater 
number of low-weight infants, a greater rate of 
prematurity and fewer healthy infants at dis-
charge from hospital among the patients with 
lupus nephropathy. Preeclampsia occurred 
exclusively in this group. The mean placental 
weight was also lower (Table 4). Women with 
antiphospholipid antibody syndrome were not 
signifi cantly different with respect to gesta-
tional loss or placental abnormalities.  
Table 3. Type of delivery, indication for cesarean section and perinatal outcome among 
pregnant lupus patients. Campinas, 1995-2002
Type of delivery n (70)* %
Vaginal 22 31.4
Cesarean section 48 68.6
Fetal distress 32 66.6
Breech presentation 3 6.3
Repeated cesarean section 2 4.2
Other indications 11 22.9
Perinatal morbidity-mortality (n = 77)
Gestational loss rate (%) 14 18.2
Abortion 6 7.8
Fetal death 3 3.9
Neonatal death 5 6.5
Living 63 81.8
Weight: AGA 49 77.7
Weight: SGA 14 22.3
Prematurity rate 34 50.0
mean SD
Weight of newborn (g) 2324.35 866.57
AGA = adequate for gestational age; SGA = small for gestational age; SD = standard deviation.
* 6 cases of abortion were excluded.
Table 4. Results according to systemic lupus erythematosus (SLE) fl are-up and SLE renal involvement (nephropathy) among pregnant 
women. Campinas, 1995-2002
Results Occurrence of fl are-ups No fl are-ups p Renal involvement No renal involvement p
Preeclampsia 9/58 0/10 NS 9/32 0 < 0.05
Gestational loss rate 9/58 2/10 NS 2/32 2/39 NS
Low birth weight 32/52 2/9 < 0.05 20/27 14/36 < 0.05
Prematurity 29/52 4/9 NS 7/32 5/39 NS
Small for gestational age 14/52 0/9 NS 20/27 12/36 < 0.05
Placental characteristics n = 38 n = 6 n = 9 n = 6 NS
Mean weight (g) 376.6 498 NS 330 459 < 0.05
NS = not signifi cant.
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DISCUSSION
Among woman with lupus, the interaction 
between the physiological changes to the im-
mune system brought about by pregnancy and 
the pathological changes caused by the disease 
alter the normal course of the reproductive 
process.4 A higher rate of poor perinatal out-
comes among women with systemic lupus 
erythematosus has been well-documented in 
the literature, particularly in women who have 
disease fl are-ups during pregnancy, as was the 
case in the present series. In the literature, the 
fl are-up rates during pregnancy range from 13 
to 60%. This wide range may be explained 
by the absence of a universal standard for 
diagnosing lupus fl are-ups, which is done 
subjectively in clinical practice. 
Various indices have been created in an 
attempt to standardize the criteria that defi ne 
fl are-ups of this disease.8 These indices do not 
focus specifi cally on pregnant lupus patients 
and this makes their application in pregnancy 
diffi cult, since the clinical and laboratory 
standards of normality vary during this phase. 
However, in the absence of an adequate index 
for assessing pregnant women, and since the 
study demanded a non-subjective standard 
for defi ning disease fl are-ups, we opted to 
use one of these existing indexes: the systemic 
lupus erythematosus disease activity index 
(SLEDAI).8 On the basis of this index, we 
defi ned groups of patients in whom the disease 
fl ared up or did not, in order to compare vari-
ables. In this study sample, fl are-ups occurred 
in 85.3% of cases. This large difference in the 
numbers of patients with and without fl are-
ups, in comparison with other studies may be 
indicative of a lack of adequate contraceptive 
counseling in this population. In view of the 
importance of not having disease fl are-ups 
around the time of a planned conception, this 
may have been a factor associated with the 
poor maternal and perinatal outcomes.
In the present study, not all the patients 
fulfi lled at least four of the ACR criteria, which 
is the minimum requirement for reaching a 
confi rmed diagnosis of lupus. However, these 
patients were managed in the same way as 
those with confi rmed diagnosis, because of 
the strongly suggestive signs and symptoms 
presented and because SLE is an evolutive 
disease in which there may be a limited range 
of symptoms in its initial phase. On the other 
hand, careful prenatal care for these women 
may reduce the gestational risks and poor 
perinatal outcomes.
With regard to maternal complications, 
preeclampsia occurred only in patients who 
had fl are-ups, and particularly in those with 
renal involvement. The incidence of prema-
turity was higher in this group of patients, 
which leads us to conclude that patients with 
maternal complications related to lupus fl are-
ups present higher perinatal risk. Differentia-
tion between lupus fl are-ups and preeclampsia 
is diffi cult in clinical practice. Preeclampsia 
occurs in approximately 13% of patients 
with lupus and is frequently confused with 
lupus nephritis.4 Some clinical and laboratory 
abnormalities are similar in these two condi-
tions, such as edema, arterial hypertension, 
thrombocytopenia and other alterations in 
blood coagulation, and proteinuria. In ad-
dition, growth disorders and fetal vitality 
disorders may occur.
The laboratory test findings that may 
help in reaching a differential diagnosis 
are: abnormal urinary sedimentation with 
the presence of erythrocyte dysmorphism 
and cell casts, which are present in lupus 
nephritis, whereas preeclampsia is defined 
by the presence of isolated proteinuria; and 
hypocomplementemia and increased anti-
DNA antibody titers, which are present in 
lupus nephritis and not in preeclampsia.9,10 
Nevertheless, both conditions are seri-
ous and, while the treatment should be 
different in each case with respect to chang-
ing the immunosuppressors or increasing 
their doses if lupus flare-up is the first 
hypothesis, various complications such 
as changes in fetal vitality and maternal 
arterial hypertension should be treated 
similarly in both conditions.
The gestational loss rate, calculated 
from the sum of the percentages of miscar-
riages, fetal deaths and neonatal deaths, 
was 18.2%. In a previous study carried out 
in our center, in which 40 cases were ana-
lyzed over a period of nine years, this rate 
was 30%. This possibly demonstrates that 
some improvement has occurred in the care 
provided for pregnant lupus patients over 
recent years.11 However, this current rate 
is still much higher than what is found in 
normal pregnancies, albeit compatible with 
data in the literature from studies carried 
out among lupus patients.12
In the literature, a greater number of cases 
of miscarriage have been reported associated 
with antiphospholipid antibody syndrome. 
However, in our study, there was no statisti-
cally signifi cant difference in the number of 
miscarriages between the two groups, perhaps 
due to the restricted sample size. The presence 
of APS was also not associated with gestational 
loss. It should be emphasized that, in all cases 
of fetal death, there was some degree of lu-
pus renal involvement. These results are in 
agreement with reports in the literature, thus 
suggesting that lupus nephritis is predictive of 
poor prognosis for pregnancy.13
Pregnant SLE patients are normally 
referred for normal labor and delivery.  How-
ever, the repercussions of their condition on 
the placenta and fetus, particularly if anti-
cardiolipin antibody is present, increase the 
incidence of chronic or acute fetal distress and 
consequently increase the cesarean section rate 
among these women.11
The prematurity rate was high, reaching 
74.1% among those with renal involvement, 
and this resulted in poor gestational prognosis, 
even among the patients whose pregnancy 
resulted in a live conceptus. In addition, pre-
maturity in itself defi nes a greater degree of 
severity of neonatal morbidity, thus making 
the perinatal prognosis for such pregnancies 
even poorer.
The small-for-gestational-age rate (22.3%) 
was also higher than in normal populations, 
and it is important to stress the fact that in all 
these cases the mothers had disease fl are-ups 
during pregnancy. In the literature, reports 
describe better prognosis for pregnancies in 
which no fl are-ups occur, and recommend 
pregnancy only after a one-year period without 
disease fl are-ups.1,2 In such cases, the aggres-
sion to the placenta is expected to be less, thus 
allowing adequate intrauterine development.
With regard to histology, although not 
all the placentas were analyzed, and despite 
the fact that the analyses were not specifi cally 
carried out for the purposes of this study, a 
greater rate of abnormalities was found in the 
placentas of this study population, particularly 
concerning the proportion of infarcted areas 
(more than 10%). Nevertheless, a comparative 
study with normal placentas is required, to 
evaluate the importance of these abnormali-
ties. Immunohistochemistry would provide 
further important data for analyzing the 
physiopathology of the disease.
CONCLUSIONS
There was a statistically signifi cant dif-
ference with regard to the rate of low-weight 
newborn infants, between patients who had 
lupus fl are-ups during pregnancy and those 
who did not. SLE patients with renal involve-
ment during pregnancy had significantly 
greater rates of preeclampsia, prematurity and 
low-weight newborn infants. They also had 
smaller placentas than did the other patients 
with lupus. The presence of antiphospholipid 
antibodies was not related to poorer perinatal 
outcomes in this study sample.
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RESUMO
Lúpus eritematoso sistêmico e gravidez: evolução clínica, resultados maternos e perinatais e achados 
placentários
CONTEXTO E OBJETIVO:  O lúpus eritematoso sistêmico é uma doença crônica que acomete preferencial-
mente mulheres em idade reprodutiva. A associação entre lúpus e gravidez é problemática e os resultados 
maternos e perinatais são piores que na população geral. O objetivo foi determinar os resultados de 76 
gestações de 67 mulheres lúpicas segundo a atividade da doença.
TIPO DE ESTUDO E LOCAL: Estudo clínico descritivo avaliando a evolução de gestantes lúpicas seguidas no 
Ambulatório de Pré-Natal Especializado do Centro de Atenção Integral à Saúde da Mulher, Universidade 
Estadual de Campinas (CAISM/Unicamp), no período de 1995 a 2002. 
MÉTODOS: Os dados foram coletados a partir de uma fi cha pré-codifi cada. As mulheres foram divididas 
em dois grupos segundo atividade do lúpus eritematoso sistêmico (LES) na gestação, conforme o índice 
de atividade de doença lúpica SLEDAI (Systemic Lupus Erythematosus Disease Activity Index). A presença 
ou não de atividade de doença e de envolvimento renal foram consideradas variáveis independentes e 
os demais resultados as variáveis dependentes.
RESULTADOS: A doença em atividade durante a gestação ocorreu em 85,3% dos casos, sendo o acometi-
mento renal o mais importante, relacionando-se a um maior número de mulheres que tiveram pré-eclâmpsia 
e pior evolução perinatal. Restrição do crescimento intra-uterino foi mais freqüente nas mulheres com doença 
ativa. O peso da placenta também foi signifi cativamente menor nas mulheres com envolvimento renal. 
CONCLUSÕES: A atividade da doença e o envolvimento renal do LES na gestação associam-se com o 
aumento de complicações maternas e perinatais.
PALAVRAS-CHAVE: Lupus. Gestação. Perinatologia. Placenta. Saúde materna.
